Enable job alerts via email!
Boost your interview chances
Create a job specific, tailored resume for higher success rate.
A leading company in RNA interference therapeutics is seeking a Director of R&D Financial Planning & Analysis. This hybrid role involves strategic financial support for global development programs, collaboration with various teams, and the development of financial dashboards. Ideal candidates will have extensive experience in finance and the biotech industry, along with strong interpersonal skills.
This role is considered Hybrid.
Overview
Reporting to the Head of R&D Finance, the Director of R&D Financial Planning & Analysis is a key member of Alnylam's Finance team. This role will work closely with business leaders at all levels of the organization and will be focused on providing strategic financial support to the company's global development program teams.
This position is hybrid and will be primarily located in Cambridge, MA.
Key Responsibilities
Qualifications
About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has pioneered RNA interference (RNAi) therapeutics, transforming scientific discovery into innovative medicines for rare and common diseases. Founded in 2002, Alnylam continues to lead the RNAi revolution, turning science into reality.
Our culture: Our people-first culture is driven by core values: innovation, openness, urgency, excellence, and commitment. Recognized globally as a top employer, we prioritize inclusivity, belonging, and empowering employees to bring their authentic selves to work, fostering groundbreaking medical advances.